SCPS
Income statement / Annual
Last year (2022), Scopus BioPharma Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Scopus BioPharma Inc.'s net income was -$11.61 M.
See Scopus BioPharma Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.68 M
|
$15.02 M
|
$7.42 M
|
$463.11 K
|
$277.54 K
|
| General & Administrative Expenses |
$9.03 M
|
$12.61 M
|
$2.73 M
|
$2.23 M
|
$408.43 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.03 M
|
$12.61 M
|
$2.73 M
|
$2.23 M
|
$408.43 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.71 M
|
$27.63 M
|
$10.16 M
|
$2.69 M
|
$685.96 K
|
| Cost And Expenses |
$11.71 M
|
$27.63 M
|
$10.16 M
|
$2.69 M
|
$685.96 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$774.68 K
|
$706.45 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.73 K
|
$1.50 K
|
$1.44 K
|
$664.00
|
$161.14 K
|
| EBITDA |
-$11.71 M |
-$26.18 M |
-$10.15 M |
-$2.69 M |
-$685.96 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$681.21 K
|
-$706.45 K
|
$0.00
|
$0.00
|
| Income Before Tax |
-$11.71 M
|
-$26.95 M
|
-$10.86 M
|
-$2.69 M
|
-$685.96 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$105.05 K
|
$774.68 K
|
$706.45 K
|
$0.00
|
$0.00
|
| Net Income |
-$11.61 M
|
-$27.73 M
|
-$11.57 M
|
-$2.69 M
|
-$685.96 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.55 |
-1.61 |
-0.87 |
-0.18 |
-0.0458 |
| EPS Diluted |
-0.55 |
-1.61 |
-0.87 |
-0.18 |
-0.0458 |
| Weighted Average Shares Out |
$21.09 M
|
$17.25 M
|
$13.36 M
|
$14.98 M
|
$14.98 M
|
| Weighted Average Shares Out Diluted |
$21.09 M
|
$17.25 M
|
$13.36 M
|
$14.98 M
|
$14.98 M
|
| Link |
|
|
|
|
|
